[{"data": {"name": "Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Dae Hyun Yoo", "@type": "Person"}, {"name": "Nenad Prodanovic", "@type": "Person"}, {"name": "Janusz Jaworski", "@type": "Person"}, {"name": "Pedro Miranda", "@type": "Person"}, {"name": "Edgar Ramiterre", "@type": "Person"}, {"name": "Allan Lanzon", "@type": "Person"}, {"name": "Asta Baranauskaite", "@type": "Person"}, {"name": "Piotr Wiland", "@type": "Person"}, {"name": "Carlos Abud-Mendoza", "@type": "Person"}, {"name": "Boycho Oparanov", "@type": "Person"}, {"name": "Svitlana Smiyan", "@type": "Person"}, {"name": "HoUng Kim", "@type": "Person"}, {"name": "Sang Joon Lee", "@type": "Person"}, {"name": "SuYeon Kim", "@type": "Person"}, {"name": "Won Park", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://ard.bmj.com/content/76/2/355.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "BMJ", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1136/annrheumdis-2015-208786", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCL8ipaVcWa2h-CT6Q756m9drQX-CD6AdrPhHe8xM-CRAzpCtEAMSWe", "propertyID": "ISCC"}], "datePublished": "2016-04-29"}, "schema": "schema.org", "mediatype": "application/ld+json"}]